ABOUT THIS EVENT Verona Pharma plc (Nasdaq: VRNA), a clinical-stage biopharmaceutical company focused on respiratory diseases, rings the Nasdaq Closing Bell remotely from across the country. In ...

LONDON and RALEIGH, N.C., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory ...

ADVISORY, Oct. 06, 2017 (GLOBE NEWSWIRE) -- What:Verona Pharma plc (Nasdaq:VRNA), a clinical stage biopharmaceutical company focused on the deve ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...

Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) have been assigned a consensus recommendation of “Buy” from the seven ratings firms that are covering the stock, ...

LONDON and RALEIGH, N.C., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on ...

The latest price target for Verona Pharma (NASDAQ:VRNA) was reported by Wells Fargo on April 30, 2025. The analyst firm set a price target for $107.00 expecting VRNA to rise to within 12 months (a ...

Amneal announced that Chirag and Chintu Patel, co-founders and co-CEOs, will ring the Nasdaq closing bell on Tuesday, April 2. “As entrepreneurs who founded Amneal in 2002, we are pleased to ...

Virpax to Ring NASDAQ Closing Bell on July 24, 2023. ... 2023. Virpax Pharmaceuticals, Inc. to Ring NASDAQ Closing Bell on July 24, 2023. July 24, 2023 07:00 AM Eastern Daylight Time. BERWYN, Pa ...

Verona Pharma (Nasdaq: VRNA), a biopharmaceutical company focused on respiratory diseases, visits the Nasdaq MarketSite in Times Square, to celebrate the approval of Ohtuvayre TM (ensifentrine) in ...

LONDON and RALEIGH, N.C., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, ...

LONDON and RALEIGH, N.C., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (VNAPF) (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused ...